Skip to main navigation Skip to search Skip to main content

Correction to: Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer (Oncogene, (2020), 39, 23, (4567-4580), 10.1038/s41388-020-1316-2)

  • Ok Seon Kwon
  • , Haeseung Lee
  • , Hyeon Joon Kong
  • , Eun Ji Kwon
  • , Ji Eun Park
  • , Wooin Lee
  • , Seungmin Kang
  • , Mirang Kim
  • , Wankyu Kim
  • , Hyuk Jin Cha

Research output: Contribution to journalComment/debate

Abstract

In the originally published version, the grant number of Dr Kim Wankyu was wrongly described in the original paper by mistake. This work was supported by a grant from the National Research Foundation of Korea (NRF-2017M3C9A5028691 from H-JC, NRF-2019R1C1C1008710 from O-SK and NRF- 2017M3C9A5028690 from WK). The original version was corrected.

Original languageEnglish
Pages (from-to)1921
Number of pages1
JournalOncogene
Volume40
Issue number10
DOIs
StatePublished - 10 Mar 2021

Bibliographical note

Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Nature Limited.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Correction to: Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer (Oncogene, (2020), 39, 23, (4567-4580), 10.1038/s41388-020-1316-2)'. Together they form a unique fingerprint.

Cite this